Inhibe la anhidrasa carbónica del Helicobacter pylori | 05 JUL 22

Famotidina, un fármaco antiulceroso

Aspectos interesantes relacionados con su mecanismo de inhibición de las AC, ofreciendo la posibilidad de desarrollar antibacterianos con un nuevo mecanismo de acción
INDICE:  1. Texto principal | 2. Texto principal
Texto principal

Bibliografía

(1) Suzuki, J.; Habu, Y.; Araki, A.; Suzuki, T.; Satoh, K.; Nagami, H.; Harada, R.; Tano, N.; Kusaka, M.; Fujioka, Y.; Fujimura, T.; Shigeto, N.; Oumi, T.; Miwa, J.; Miwa, H.; Fujimoto, K.; Kinoshita, Y.; Haruma, K. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study. BMC Gastroenterol. 2012, 12, 42.

(2) Howden, C. W. Clinical pharmacology of omeprazole. Clin.Pharmacokinet. 1991, 20, 38.

(3) Ahmadi, A.; Ebrahimzadeh, M. A.; Ahmad-Ashrafi, S.; Karami, M.; Mahdavi, M. R.; Saravi, S. S. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists. Fundam. Clin. Pharmacol. 2011, 25, 72.

(4) De Simone, G.; Pizika, G.; Monti, S. M.; Di Fiore, A.; Ivanova, J.;Vozny, I.; Trapencieris, P.; Zalubovskis, R.; Supuran, C. T.; Alterio, V. Hydrophobic substituents of the phenylmethylsulfamide moiety can be used for the development of new selective carbonic anhydrase inhibitors. BioMed Res. Int. 2014, 2014, 523210.

(5) Demir, Y.; Nadarog?lu, H.; Demir, N. Effects of omeprazole, famotidine, and ranitidine on the enzyme activities of carbonic anhydrase from bovine stomach in vitro and rat erythrocytes in vivo. Biol. Pharm. Bull. 2004, 27, 1730.

(6) Supuran, C. T. Structure and function of carbonic anhydrases. Biochem. J. 2016, 473, 2023.

(7) Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discovery 2008, 7, 168.

(8) Supuran, C. T. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin. Drug Discovery 2017, 12, 61.

(9) Lo¨nnerholm, G.; Selking, O.; Wistrand, P. J. Amount and distribution of carbonic anhydrases CA I and CA II in the gastrointestinal tract. Gastroenterology 1985, 88, 1151.

(10) Carter, M. J.; Parsons, D. S. The isoenzymes of carbonic anhydrase: tissue, subcellular distribution and functional significance, with particular reference to the intestinal tract. J. Physiol. 1971, 215, 71.

(11) Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 1971, 246, 2561.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024